Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Serum MicroRNA Signature Accurately Identifies Diffuse Intrinsic Pontine Glioma in Pediatric Cohort

3 hours ago 9

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

A fifteen-microRNA blood-based signature identified pediatric diffuse intrinsic pontine glioma with high accuracy in an independent retrospective test set, according to an investigation published in the Journal of Translational Medicine. The study evaluated circulating serum microRNA profiles to address the severe diagnostic and analytical challenges posed by diffuse intrinsic pontine glioma, also termed pontine diffuse midline glioma.

The researchers sought to determine whether circulating serum microRNAs could establish an effective diagnostic signature capable of discriminating diffuse intrinsic pontine glioma from pediatric control patients with a documented history of non-central nervous system malignancies. Beyond diagnostic classification, the investigators evaluated whether differentially expressed circulating microRNAs could offer biologically interpretable insight into the disease programs and microenvironmental mechanisms active in this lethal childhood tumor.

The study cohort comprised serum microRNA profiles collected from 47 patients with diffuse intrinsic pontine glioma and 42 pediatric non-glioma oncology controls who had histories of non-central nervous system malignancies. Investigators divided these 89 participants into two distinct analytical groups: an initial training cohort consisting of 23 patients with diffuse intrinsic pontine glioma and 21 controls, alongside an independent retrospective test cohort comprising 24 patients with diffuse intrinsic pontine glioma and 21 controls.

To generate the diagnostic classification system, investigators applied least absolute shrinkage and selection operator logistic regression within the initial training cohort, utilizing internal 10-fold cross-validation during the feature selection process. This mathematical modeling pipeline isolated a final signature composed of 15 microRNAs.

During model construction and tuning in the training set, internal cross-validation yielded an initial accuracy of 97.7 percent, representing correct identification in 43 of 44 evaluated cases. The authors noted that this internal training figure could represent an optimistic estimate because it arose during feature selection and model optimization. Subsequent evaluation of the locked fifteen-microRNA classifier on the independent retrospective test cohort confirmed high diagnostic performance, demonstrating an overall accuracy of 95.6 percent across 43 of 45 test cases, supported by a 95 percent confidence interval spanning 84.9 percent to 99.5 percent.

The locked classifier demonstrated complete sensitivity within the test cohort, successfully categorizing all 24 diffuse intrinsic pontine glioma specimens for a sensitivity rate of 100.0 percent, with a 95 percent confidence interval ranging between 85.8 percent and 100.0 percent. Specificity across the control group reached 90.5 percent, corresponding to accurate classification in 19 of 21 control samples, with a 95 percent confidence interval between 69.6 percent and 98.8 percent. Quantitative analysis of the model’s predicted probabilities revealed strong separation between diagnostic classes, generating consistently high disease probabilities across diffuse intrinsic pontine glioma samples and low estimated probabilities across the majority of control samples.

In parallel with predictive modeling, the investigators conducted differential microRNA expression analyses separately across the training and test cohorts to uncover biological pathways. This discovery analysis identified 70 significantly deregulated microRNAs in the training set, consisting of 58 upregulated and 12 downregulated molecules in diffuse intrinsic pontine glioma samples. In the independent test set, differential analysis identified 65 significant microRNAs, comprising 55 upregulated and 10 downregulated molecules. Candidates exhibiting concordant deregulation across both cohorts were subsequently prioritized for functional target prediction and cellular pathway enrichment calculations.

From these concordantly altered molecules, the researchers established a biologically prioritized panel of six microRNAs that directly implicated key developmental, signaling, and immunological cascades. Target predictions linked this panel to neural development, axonogenesis, cadherin-mediated cell adhesion, mitogen-activated protein kinase and Ras signaling, transforming growth factor-beta pathways, and Wnt cascades, along with immune-related programs. These convergent molecular signatures highlight disease-associated pathways and provide biological interpretability that extends beyond statistical classification, offering a molecular framework for monitoring disease processes in the pontine microenvironment.

The authors concluded that circulating serum microRNA profiling successfully discriminates pediatric patients with diffuse intrinsic pontine glioma from pediatric oncologic controls within retrospective cohorts.

Subject of Research: Diagnostic classification and biological pathway profiling of pediatric diffuse intrinsic pontine glioma using circulating serum microRNAs

Article Title: Circulating miRNA deregulation in diffuse intrinsic pontine glioma: diagnostic classification and biological pathway insights

Article References: Novello, V., Dossena, C., Lucchetta, M., Biassoni, V., Schiavello, E., Nigro, O., Oriani, M., Morelli, F., Mortarini, R., Molla, A., Vegetti, C., Pecori, E., Vennarini, S., Massimino, M., & Cecco, L. D. (2026). Circulating miRNA deregulation in diffuse intrinsic pontine glioma: diagnostic classification and biological pathway insights. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09245-0

Image Credits: AI Generated

DOI: 10.1186/s12967-026-09245-0

Keywords: diffuse intrinsic pontine glioma, pontine diffuse midline glioma, serum microRNAs, liquid biopsy, pediatric neuro-oncology, LASSO logistic regression, diagnostic classification, molecular biomarkers, neural development, axonogenesis, cadherin signaling, MAPK Ras signaling, TGF-beta signaling, Wnt signaling, tumor microenvironment, pediatric oncology

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway